• Toward a better understanding of the experience of patients with moderate penetrance breast cancer gene pathogenic/likely pathogenic variants: A focus on ATM and CHEK2.
• McCormick S, Hicks S, Wooters M, Grant C.
• J Genet Couns. 2022 Mar 4. doi: 10.1002/jgc4.1568. Epub ahead of print.

• PMID: 35246915
• PubMed abstract
• Source abstract